Intellia Therapeutics Inc buy Truist Financial Co.
Start price
10.11.25
/
50%
€8.65
Target price
10.11.26
€12.11
Performance (%)
-11.08%
Price
12.12.25
€7.69
Summary
This prediction is currently active. The prediction for Intellia Therapeutics Inc disappoints with a performance of -11.08%. This prediction currently runs until 10.11.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -6.699% | -6.699% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) had its "buy" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $14.00 price target on the stock, down previously from $25.00.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€8.43
04.03.25
04.03.25
€47.44
04.03.26
04.03.26
-8.82%
12.12.25
12.12.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€23.43
24.06.24
24.06.24
€111.85
24.06.25
24.06.25
-64.98%
25.06.25
25.06.25